SGLT2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis (EDKA) in Hematologic Malignancy Patients: A Case Series. uri icon

authors

  • Andrew Artz, MD, MS
  • Nguyen, Tiffany
  • Samoa, Raynald
  • Kim, Hoim
  • Tse, Wyndie
  • Jin, Rami
  • Goutnik, Svetlana

publication date

  • October 8, 2025